THE EFFECTIVENESS OF THE ANTI-TUMOR NECROSIS FACTOR THERAPY INFLIXIMAB IN NEURO-BEHCET'S DISEASE: A SYSTEMATIC REVIEW AND META-ANALYSIS

被引：0
|
作者：
Mohammed, R. Hamdy Abdellatif [1 ]
Woldeamanuel, Y. [2 ]
机构：
[1] Cairo Univ, Rheumatol & Rehabititat, Kasr Alainy Sch Med, Cairo, Egypt
[2] Stanford Univ, Stanford Headache Ctr, Dept Neurol, Ctr Innovat Global Hlth,Sch Med, Stanford, CA USA
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2021年 / 80卷
关键词：
D O I：
10.1136/annrheumdis-2021-eular.52
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
AB0385
引用
收藏
页码：1220 / 1220
页数：1
相关论文
共 50 条
  • [41] Intraarticular anti-tumor necrosis factor alpha antibody in recalcitrant arthritis of Behcet's disease
    Andonopoulos, AP
    Meimaris, N
    Daoussis, D
    Bounas, A
    Yiannopoulos, G
    ANNALS OF THE RHEUMATIC DISEASES, 2003, 62 : 450 - 450
  • [42] Antiangiogenic effects of anti-tumor necrosis factor a therapy with infliximab in psoriatic arthritis
    Cañete, JD
    Pablos, JL
    Sanmartí, R
    Mallofré, C
    Marsal, S
    Maymó, J
    Gratacós, J
    Mezquita, J
    Mezquita, C
    Cid, MC
    ARTHRITIS AND RHEUMATISM, 2004, 50 (05): : 1636 - 1641
  • [43] Treatment of complicated sarcoidosis with infliximab anti-tumor necrosis factor-α therapy
    Yee, AMF
    Pochapin, MB
    ANNALS OF INTERNAL MEDICINE, 2001, 135 (01) : 27 - 31
  • [44] Efficacy, safety and pharmacokinetics of biosimilars of anti-tumor necrosis factor-α agents in rheumatic diseases; A systematic review and meta-analysis
    Komaki, Yuga
    Yamada, Akihiro
    Komaki, Fukiko
    Kudaravalli, Praneeth
    Micic, Dejan
    Ido, Akio
    Sakuraba, Atsushi
    JOURNAL OF AUTOIMMUNITY, 2017, 79 : 4 - 16
  • [45] Effectiveness and Safety of Chinese Medicine Decoctions for Behcet's Disease: A Systematic Review and Meta-Analysis
    Yan, Jingxian
    Yan, Yi
    Young, Andrew
    Yan, Zhiyong
    Yan, Zhimin
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2021, 2021
  • [46] Pneumocystis carinii pneumonia during maintenance anti-tumor necrosis factor-α therapy with infliximab for Crohn's disease
    Velayos, FS
    Sandborn, WJ
    INFLAMMATORY BOWEL DISEASES, 2004, 10 (05) : 657 - 660
  • [47] Vedolizumab versus ustekinumab in Crohn's disease with prior anti-tumor necrosis factor failure: an updated meta-analysis
    Milioli, Natalia Junkes
    Fernandes, Matheus Vanzin
    Correa, Tulio L.
    Antunes, Vanio
    Martins, Otavio Cosendey
    de Mesquita, Cynthia Florencio
    Baraldo, Stefano
    Furfaro, Federica
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2024, 36 (09) : 1068 - 1074
  • [48] Neuro-Behcet's disease, its mimickers and anti-TNF therapy: a case-based review
    Neves, F. S.
    Ferreira, R. M.
    Pereira, I. A.
    Zimmermann, A. F.
    Lin, K.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2013, 31 (03) : S133 - S140
  • [49] Comparative Efficacy of Novel Biologics, Anti-tumor Necrosis Factor Agents, and Immunomodulators to Prevent Postoperative Recurrence in Crohn's Disease: A Systematic Review and Network Meta-analysis
    Duan, Shihao
    Chen, Pingrun
    Liang, Chang
    Zhang, Yan
    JOURNAL OF CROHNS & COLITIS, 2024, 19 (02):
  • [50] Opportunistic Infections With Anti-Tumor Necrosis Factor-α Therapy in Inflammatory Bowel Disease: Meta-Analysis of Randomized Controlled Trials
    Ford, Alexander C.
    Peyrin-Biroulet, Laurent
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2013, 108 (08): : 1268 - 1276
12345